Literature DB >> 3456558

Synthetic oligonucleotide tails inhibit in vitro and in vivo translation of SP6 transcripts of maize zein cDNA clones.

G Galili, E E Kawata, R E Cuellar, L D Smith, B A Larkins.   

Abstract

A maize zein cDNA clone was used to synthesize mRNA with the SP6 in vitro transcription system. Although we obtained full-length transcripts of the cDNA sequence, these were inefficient templates for protein synthesis. Removal of the 5' oligo(G) sequence that was synthesized during the cDNA cloning procedure allowed efficient translation of the mRNAs in a wheat germ cell-free protein synthesis system or in Xenopus laevis oocytes. The alteration in translational efficiency did not result from an interaction of the 5' oligo(G) homopolymer tail with the 3' oligo(C) sequence, as transcripts with or without the oligo(C) tail were translated similarly in both protein synthesis systems. Ribosome interaction with the mRNA may be affected due either to the secondary structure of the oligo(G) sequence itself, or an unusual secondary structure between the oligo(G) sequence and another region in the mRNA. Synthetic oligonucleotides at the 5' end of cloned cDNA sequences may generally be inhibitory for translation of mRNAs transcribed in vitro.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3456558      PMCID: PMC339520          DOI: 10.1093/nar/14.3.1511

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  20 in total

1.  Synthesis of mitochondrial RNA by full-grown and maturing oocytes of Rana pipiens and Xenopus laevis.

Authors:  A C Webb; M J LaMarca; L D Smith
Journal:  Dev Biol       Date:  1975-07       Impact factor: 3.582

2.  Insertion mutagenesis to increase secondary structure within the 5' noncoding region of a eukaryotic mRNA reduces translational efficiency.

Authors:  J Pelletier; N Sonenberg
Journal:  Cell       Date:  1985-03       Impact factor: 41.582

3.  Partial purification and properties of a pre-mRNA splicing activity.

Authors:  P R DiMaria; G Kaltwasser; C J Goldenberg
Journal:  J Biol Chem       Date:  1985-01-25       Impact factor: 5.157

4.  Oogenesis in Xenopus laevis (Daudin). I. Stages of oocyte development in laboratory maintained animals.

Authors:  J N Dumont
Journal:  J Morphol       Date:  1972-02       Impact factor: 1.804

5.  Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter.

Authors:  D A Melton; P A Krieg; M R Rebagliati; T Maniatis; K Zinn; M R Green
Journal:  Nucleic Acids Res       Date:  1984-09-25       Impact factor: 16.971

6.  Functional messenger RNAs are produced by SP6 in vitro transcription of cloned cDNAs.

Authors:  P A Krieg; D A Melton
Journal:  Nucleic Acids Res       Date:  1984-09-25       Impact factor: 16.971

7.  In vitro-synthesized adenovirus 2 messenger RNA precursors are accurately spliced by nuclear extracts.

Authors:  C J Goldenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

8.  Synthesis and deposition of zein in protein bodies of maize endosperm.

Authors:  B A Larkins; W J Hurkman
Journal:  Plant Physiol       Date:  1978-08       Impact factor: 8.340

9.  Human beta-globin pre-mRNA synthesized in vitro is accurately spliced in Xenopus oocyte nuclei.

Authors:  M R Green; T Maniatis; D A Melton
Journal:  Cell       Date:  1983-03       Impact factor: 41.582

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  11 in total

1.  Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system.

Authors:  A Aruffo; B Seed
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

2.  The synthesis of a 19 kilodalton zein protein in transgenic petunia plants.

Authors:  J D Williamson; G Galili; B A Larkins; S B Gelvin
Journal:  Plant Physiol       Date:  1988-12       Impact factor: 8.340

3.  Normal and lysine-containing zeins are unstable in transgenic tobacco seeds.

Authors:  T Ohtani; G Galili; J C Wallace; G A Thompson; B A Larkins
Journal:  Plant Mol Biol       Date:  1991-01       Impact factor: 4.076

4.  Translational regulation of human beta interferon mRNA: association of the 3' AU-rich sequence with the poly(A) tail reduces translation efficiency in vitro.

Authors:  G Grafi; I Sela; G Galili
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

5.  Modulations of the in vitro translational efficiencies of Yellow Fever virus mRNAs: interactions between coding and noncoding regions.

Authors:  A Ruiz-Linares; M Bouloy; M Girard; A Cahour
Journal:  Nucleic Acids Res       Date:  1989-04-11       Impact factor: 16.971

6.  In vitro transcription and translational efficiency of chimeric SP6 messenger RNAs devoid of 5' vector nucleotides.

Authors:  S A Jobling; C M Cuthbert; S G Rogers; R T Fraley; L Gehrke
Journal:  Nucleic Acids Res       Date:  1988-05-25       Impact factor: 16.971

7.  Characterization of Polypeptides Corresponding to Clones of Maize Zein mRNAS.

Authors:  G Galili; E E Kawata; B A Larkins
Journal:  Plant Physiol       Date:  1987-06       Impact factor: 8.340

8.  Differential Accumulation of a Transcript Driven by the CaMV 35S Promoter in Transgenic Tobacco.

Authors:  J D Williamson; M E Hirsch-Wyncott; B A Larkins; S B Gelvin
Journal:  Plant Physiol       Date:  1989-08       Impact factor: 8.340

9.  Identification of functional domains of the aryl hydrocarbon receptor nuclear translocator protein (ARNT).

Authors:  S Reisz-Porszasz; M R Probst; B N Fukunaga; O Hankinson
Journal:  Mol Cell Biol       Date:  1994-09       Impact factor: 4.272

10.  Molecular cloning of two isoinhibitor forms of chymotrypsin inhibitor 1 (CI-1) from barley endosperm and their expression in normal and mutant barleys.

Authors:  M S Williamson; J Forde; M Kreis
Journal:  Plant Mol Biol       Date:  1988-11       Impact factor: 4.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.